Evidence map›Paper›PMID 31325249›Full record

ArticlePhysiological reports2019

Extracellular vesicles from human bone marrow mesenchymal stem cells repair organ damage caused by cadmium poisoning in a medaka model.

Tomomi Matsukura, Chisako Inaba, Esther A Weygant, Daiki Kitamura, Ralf Janknecht, Hiroyuki Matsumoto, Deborah P Hyink, Shosaku Kashiwada, Tomoko Obara

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. The Chemokine Receptors Ccr5 and Cxcr6 Enhance Migration of Mesenchymal Stem Cells into the Degenerating Retina.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Article
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Tomomi MatsukuraDepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Chisako InabaDepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Esther A WeygantDepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Daiki KitamuraDepartment of Life Sciences, Toyo University, Gunma, Japan.
Ralf JanknechtDepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Hiroyuki MatsumotoDepartment of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Deborah P HyinkDepartment of Medicine, Baylor College of Medicine, Houston, Texas.
Shosaku KashiwadaDepartment of Life Sciences, Toyo University, Gunma, Japan.
Tomoko ObaraDepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.ORCID 0000-0001-9890-6297
University of Oklahoma Health Sciences Center · USToyo University · JPBaylor College of Medicine · USKurume University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment modalities for kidney disease caused by long-term exposure to heavy metals, such as cadmium (Cd), are limited. Often, chronic, long-term environmental exposure to heavy metal is not recognized in the early stages; therefore, chelation therapy is not an effective option. Extracellular vesicles (EVs) derived from stem cells have been demonstrated to reduce disease pathology in both acute and chronic kidney disease models. To test the ability of EVs derived from human bone marrow mesenchymal stem cells (hBM-MSCs) to treat Cd damage, we generated a Cd-exposed medaka model. This model develops heavy metal-induced cell damage in various organs and tissues, and shows decreased overall survival. Intravenous injection of highly purified EVs from hBM-MSCs repaired the damage to apical and basolateral membranes and mitochondria of kidney proximal tubules, glomerular podocytes, bone deformation, and improved survival. Our system also serves as a model with which to study age- and sex-dependent cell injuries of organs caused by various agents and diseases. The beneficial effects of EVs on the tissue repair process, as shown in our novel Cd-exposed medaka model, may open new broad avenues for interventional strategies.

Indexed as

AnimalsBone Marrow CellsCadmium PoisoningCells, CulturedExtracellular VesiclesHumansKidney Tubules, ProximalMesenchymal Stem CellsMesenchymal Stem Cell TransplantationMitochondriaOryziasPodocytesBonecadmiumchronic kidney diseaseextracellular vesiclesmedakamesenchymal stem cells

Identifiers

PMID31325249
PMCPMC6642321
OpenAlexW2963076691

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.